A compound, comprising: an Fe(III)-binding and/or Fe(III)-bound siderophore; one or more optional linker covalently bound to the siderophore; and daptomycin covalently bound to the linker, or, if no linker is present, then to the siderophore; or pharmaceutically acceptable salt or solvate thereof.
This invention pertains generally to compounds of Formula (A),
as further described herein, which act as beta-lactamase inhibitors, and salts, crystalline forms and formulations thereof. In certain aspects, the invention pertains to methods of using such compounds in combination with a beta-lactam antibiotic to treat infections caused by Gram-negative bacteria, including drug-resistant strains.
Slusarchyk, William A.; Dejneka, Tamara; Gordon, Eric M., Heterocycles, 1984, vol. 21, # 1, p. 191 - 210
作者:Slusarchyk, William A.、Dejneka, Tamara、Gordon, Eric M.、Weaver, Eugene R.、Koster, William H.